Endothelial Monocyte-activating Polypeptide-II in Egyptian Sickle Patients
NCT03903133
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Sickle Cell Disease
Interventions
DRUG:
Vitamin E
Sponsor
Ain Shams University